Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
Sponsor: Federico Martinón Torres
Summary
A longitudinal observational study based on routinely collected data on hospital and health care use for RSV infections will be undertaken. The Galician public health registries will be used for data collection including baseline information and follow-up data. Historical data will be retrieved for comparison purposes. The study aims to observe and analyze data from all the eligible children in Galicia for nirsevimab treatment. The number of eligible children is expected to be approximately 14,000 per each RSV season.
Key Details
Gender
All
Age Range
1 Day - 24 Months
Study Type
OBSERVATIONAL
Enrollment
42000
Start Date
2023-09-25
Completion Date
2026-10-31
Last Updated
2023-12-26
Healthy Volunteers
Not specified
Conditions
Interventions
Nirsevimab
Nirsevimab will be administered administered in a single dose at birth for birth cohort and at the beginning of the campaign for the other cohorts under study
Locations (1)
Hospital Clínico Universitario de Santiago de Compostela
Santiago de Compostela, A Coruña, Spain